2005
Asperger Syndrome
Klin A, McPartland J, Volkmar F. Asperger Syndrome. 2005, 88-125. DOI: 10.1002/9780470939345.ch4.Peer-Reviewed Original Research
1999
Summary of the Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults With Autism and Other Pervasive Developmental Disorders
Volkmar F, Cook E, Pomeroy J, Realmuto G, Tanguay P. Summary of the Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults With Autism and Other Pervasive Developmental Disorders. Journal Of The American Academy Of Child & Adolescent Psychiatry 1999, 38: 1611-1615. PMID: 10596264, DOI: 10.1097/00004583-199912000-00028.Peer-Reviewed Original ResearchConceptsPervasive developmental disorderDevelopmental disordersRelated pervasive developmental disordersTreatment of childrenPatterns of delayCognitive skillsBehavioral problemsSyndrome expressionAutismAdolescentsDisordersChildrenCoordination of servicesPractice parametersSustained interventionsTreatment modalitiesTreatment recommendationsMental retardationIndividualsClinical careDevianceSkillsFirst yearCliniciansTreatment
1994
Lithium Augmentation of Fluvoxamine in Autistic Disorder: A Case Report
EPPERSON C, McDOUGLE C, ANAND A, MAREK G, NAYLOR S, VOLKMAR F, COHEN D, PRICE L. Lithium Augmentation of Fluvoxamine in Autistic Disorder: A Case Report. Journal Of Child And Adolescent Psychopharmacology 1994, 4: 201-207. DOI: 10.1089/cap.1994.4.201.Peer-Reviewed Original ResearchSerotonin uptake inhibitorLithium augmentationUptake inhibitorAutistic disorderMinimal clinical responseSubstantial clinical improvementWeeks of treatmentSingle case reportsSignificant adverse effectsClinical improvementClinical responseClinical evidenceCase reportSerotonin functionFluvoxamineMeaningful improvementsTreatment of autismPatientsMarked reductionRating ScaleAdverse effectsRelative efficacyDisordersWeeksTreatmentAutism: Current Concepts
Volkmar F, Cohen D. Autism: Current Concepts. Child And Adolescent Psychiatric Clinics Of North America 1994, 3: 43-52. DOI: 10.1016/s1056-4993(18)30514-5.Peer-Reviewed Original Research
1992
Clomipramine in Autism: Preliminary Evidence of Efficacy
MCDOUGLE C, PRICE L, VOLKMAR F, GOODMAN W, WARD-O'BRIEN D, NIELSEN J, BREGMAN J, COHEN D. Clomipramine in Autism: Preliminary Evidence of Efficacy. Journal Of The American Academy Of Child & Adolescent Psychiatry 1992, 31: 746-750. PMID: 1644740, DOI: 10.1097/00004583-199207000-00025.Peer-Reviewed Original ResearchConceptsAutistic disorderPreliminary evidenceObsessive-compulsive symptomsSocial relatednessImpulsive behaviorCompulsive symptomsEfficacy of clomipramineYoung adultsPrevious evidenceClomipramine treatmentSerotonin neurotransmissionDisordersAutismClomipramineSymptomsTreatmentEfficacySignificant improvementAdultsEvidenceOutpatientsPathophysiologyNeurotransmissionRelatednessFindings
1981
Group therapy in the management of manic-depressive illness.
Volkmar F, Bacon S, Shakir S, Pfefferbaum A. Group therapy in the management of manic-depressive illness. American Journal Of Psychotherapy 1981, 35: 226-34. PMID: 7258419, DOI: 10.1176/appi.psychotherapy.1981.35.2.226.Peer-Reviewed Original ResearchConceptsWeeks of hospitalizationLithium maintenance treatmentMaintenance treatmentLithium prophylaxisBipolar manic-depressive patientsLong-term therapy groupGroup of patientsMajor treatment modalityManic-depressive patientsBipolar affective illnessManic-depressive illnessCost-effective adjunctTwo-year periodLithium maintenanceTreatment modalitiesAffective illnessTherapy groupPatientsPoor candidatesIllnessGroup therapyHospitalizationProphylaxisTreatmentPsychotherapy group